PCMA: Congressional Budget Office Score of Medicare Point-of-Sale Rebates Undermines Drugmakers’ Signature Issue
"CBO's examination follows analyses by the
This score strikes the third blow to the drugmakers' long-running multi-million dollar campaign to shift blame for their own prices onto the health plans and pharmacy benefit managers (PBMs) that negotiate discounts and rebates to reduce costs. For policymakers, this should be a 'three strikes and you're out' moment.
Drugmakers set and raise prices unrelated to theĀ rebates they negotiate with pharmacy benefit managersĀ (PBMs). Many high-priced drugs like Sovaldi, which initially cost
We look forward to continuing to work with CMS to find ways to improve benefits and reduce costs in the Medicare Part D program."
PCMA is the national association representing America's pharmacy benefit managers (PBMs). PBMs administer prescription drug plans for more than 266 million Americans who have health insurance from a variety of sponsors including: commercial health plans, self-insured employer plans, union plans, Medicare Part D plans, the Federal Employees Health Benefits Program (FEHBP), state government employee plans, Medicaid plans, and others.
View original content with multimedia:http://www.prnewswire.com/news-releases/pcma-congressional-budget-office-score-of-medicare-point-of-sale-rebates-undermines-drugmakers-signature-issue-300655865.html
SOURCE
Prepare for hurricanes, severe storms
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News